At present, the main specific antigens of MM that show potential in the targeting therapy of MM include BCMA [90], HM1.24 [91], MUC-1 [92], MAGE-C1 [93], B7-H1 [94] and HSP [95]. The gene discussed is MAGEC1; the disease is Miyoshi myopathy.